Milan, InSilicoTrials has been innovating the healthcare sector for some years now, helping pharmaceutical companies reduce the time and cost of drug development using modeling & simulation. The release of two new products for oncology that have no equals on the market – PCa GnRH
MoreReston, VA; July 23, 2013– Manufacturers in the pharmaceutical, biopharmaceutical, nutraceutical and medical device industries are facing significant challenges in 2013,
MoreWaiblingen / Crailsheim – With the new FHM 1000 series, Bosch Packaging Technology, one of the leading providers of process and
MoreThis is hepatitis. Know it. Confront it. Every year on 28 July, WHO and partners mark World Hepatitis Day to
MoreKemira and General Electric (GE) are excited to announce that, effective immediately, Kemira’s Paper Segment will furnish GE Water &
MoreDifficult-to-study diseases such as Alzheimer’s, schizophrenia, and autism now can be probed more safely and effectively thanks to an innovative
More[column]The U.S. Food and Drug Administration has approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after
More[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with
MoreThe U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all
More[column]Two mutations central to the development of infantile myofibromatosis (IM) – a disorder characterized by multiple tumors involving
More[column]Advances in genetic profiling have allowed doctors to match more of their cancer patients with treatments that will target their
More